ホーム>>Signaling Pathways>> Neuroscience>> Pain Research>>R-(-)-α-Methylhistamine (hydrochloride)

R-(-)-α-Methylhistamine (hydrochloride)

カタログ番号GC18397

R-(-)-α-メチルヒスタミン (塩酸塩) は、強力で選択的な H3 ヒスタミン受容体の脳浸透性アゴニストであり、Kd は 50.3 nM です。

Products are for research use only. Not for human use. We do not sell to patients.

R-(-)-α-Methylhistamine (hydrochloride) 化学構造

Cas No.: 75614-89-0

サイズ 価格 在庫数 個数
1mg
$30.00
在庫あり
5mg
$109.00
在庫あり
10mg
$204.00
在庫あり
25mg
$436.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products
R-(-)-α-Methylhistamine is a histamine H3 receptor agonist with diverse biological activities. It inhibits the release of histamine induced by antidromic electrical stimulation of the sciatic nerve in rats when administered at doses ranging from 0.25 to 2 mg/kg, an effect that can be reversed by the selective histamine H3 receptor antagonist thioperamide . R-(-)-α-Methylhistamine (0.5-50 nmol) inhibits gastric acid secretion in rats when administered intracerebroventricularly but not intravenously. It reduces isolation-induced vocalizations and aggressive behavior in a resident-intruder test in guinea pig pups and mice, respectively. R-(-)-α-Methylhistamine (30 mg/kg) decreases freezing time in a conditioned fear stress test in rats. It also acts synergistically with fentanyl to reduce nociception and plasma extravasation in a mouse model of chronic inflammation induced by complete Freund's adjuvant.

レビュー

Review for R-(-)-α-Methylhistamine (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for R-(-)-α-Methylhistamine (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.